Conatus Pharmaceuticals (CNAT) PT Lowered to $20 at SunTrust Robinson Humphrey Apr 5, 2018 01:04AM
Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts and Strategic Initiatives at Upcoming Investor Events Feb 5, 2018 07:30AM
Conatus Announces Completion of Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares May 16, 2017 04:05PM
Conatus Pharmaceuticals (CNAT) Prices 5.2M Shares at $5.50 May 11, 2017 09:02AM
Conatus Announces Pricing of Public Offering of Common Stock May 11, 2017 09:02AM


May 10, 2017 04:04PM Conatus Pharmaceuticals (CNAT) Plans Offering of Common Stock
May 10, 2017 04:01PM Conatus Announces Proposed Public Offering of Common Stock
Dec 20, 2016 02:11PM Unusual 11 Mid-Day Movers 12/20: (CNAT) (FRED) (AKBA) Higher; (SCMP) (NPTN) (DEST) Lower (more...)
Dec 20, 2016 09:30AM Pre-Open Stock Movers 12/20: (CNAT) (AKBA) (ACAD) Higher; (NPTN) (SCMP) (GIS) Lower (more...)
Dec 20, 2016 08:21AM Conatus Pharmaceuticals' (CNAT) Price Target Raised to $26 at SunTrust
Aug 19, 2013 08:20AM SunTrust Robinson Humphrey Starts Conatus Pharmaceuticals (CNAT) at Buy
Jul 25, 2013 03:47PM Conatus Pharmaceuticals (CNAT) IPO Opens Flat, Then Sells-Off